PLoS Clinical Trials: a peer-reviewed open-access journal from the Public Library of Science

New journal from Public Library of Science Submit your trials!

Dear Colleague,

We are delighted to announce that PLoS Clinical Trials, the newest open-access journal from the Public Library of Science (PLoS), is now welcoming submissions in advance of its Spring 2006 launch. PLoS Clinical Trials will be freely accessible to all at www.plosclinicaltrials.org.

Call for Papers

We hope very much that you will support the goal of improving the reporting and availability of trial results, by submitting your work to PLoS Clinical Trials.

Benefits of publishing in PLoS Clinical Trials

  • Open access: you get the widest global audience for your work
  • Fast, rigorous peer review
  • Inclusivity: all randomized trials considered, irrespective of outcome
  • Rapid online publication
  • Listed in PubMed, articles cross-linked to trial registry records
  • All articles permanently archived in PubMed Central

Submissions are invited in particular in oncology, cardiovascular medicine, neurology, psychiatry and infectious diseases, but we welcome trials from all fields of healthcare. And remember, publication is not dependent on the results of your trial. Interim or follow-up analyses are welcomed.

Harold Varmus, Nobel Laureate and Co-founder of PLoS comments:

Members of the public participate in clinical trials, believing the results will increase knowledge. However, results are often hard to find or, worse still, are not reported at all, because journals tend to be interested in positive outcomes. PLoS Clinical Trials solves this, by providing a freely accessible online forum where all trials can be reported, irrespective of outcome.

To find out more about submitting a trial, go to www.plosclinicaltrials.org, or contact the Publications Manager at eveitch@plos.org.

Content Alerts

The best way to stay current about developments in PLoS Clinical Trials is to register for Content Alerts via the website link above. The process is simple and takes seconds. While PLoS Clinical Trials is multidisciplinary, information relevant to your specialty will be easily found through powerful, easy-to-use-linking and searching tools.

About PLoS

PLoS was founded in 2003 by Harold Varmus, Patrick Brown, and Michael Eisen as a not-for-profit organization of scientists and physicians committed to making the world's scientific and medical literature a public resource. PLoS launched its first two journals - PLoS Biology (launched 2003; Impact Factor 13.9) and PLoS Medicine (2004) as alternatives to the top-tier subscription-based biology and medicine journals. They, as well as subsequent community journals, have been received well by authors and readers.

Please contact us with your questions and feedback, which should be directed in the first instance to Emma Veitch, Publications Manager at eveitch@plos.org.

Sincerely,

PLoS Clinical Trials Advisory Board

Mike Clarke
UK Cochrane Centre, Oxford, UK

Kay Dickersin
Johns Hopkins University, Baltimore, USA

Ben Djulbegovic
H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, USA

Christian Gluud
Copenhagen University Hospital, Copenhagen, Denmark

Pisake Lumbiganon
Khon Kaen University, Khon Kaen, Thailand

Musa Mayer
Author and breast cancer patient advocate, New York, USA

Adil Shamoo
University of Maryland, Baltimore, USA

Ida Sim
University of California, San Francisco, USA

Jimmy Volmink
University of Cape Town, Cape Town, South Africa

and

Emma Veitch
Publications Manager, PLoS Clinical Trials